These observations implicate iron-catalyzed ROS in TGF-β2-associated POAG, providing novel insight into the mechanistic basis of TGF-β2-associated POAG, and therapeutic options aimed at reducing hepcidin and iron-catalyzed ROS in the TM. The gene discussed is HAMP; the disease is open-angle glaucoma.